Table 5.
Complications and sequelae associated with COVID-19 severity.
| Classification | ||||
|---|---|---|---|---|
| Mild COVID | Moderate COVID | Severe COVID | MIS-Ca | |
| Count (%) | Count (%) | Count (%) | Count (%) | |
| Nosocomial infection | 1 (0.5) | 0 | 3 (1.4) | 1 (0.5) |
| Radiculopathy | 1 (0.5) | 0 | 1 (0.5) | 0 |
| Liver disease | 1 (0.5) | 0 | 0 | 0 |
| Acute kidney injury | 0 | 1 (0.5) | 1 (0.5) | 1 (0.5) |
| Coagulopathy | 2 (0.9) | 1 (0.5) | 3 (1.4) | 2 (0.9) |
| Heart failure | 0 | 1 (0.5) | 1 (0.5) | 1 (0.5) |
| Pneumothorax | 0 | 1 (0.5) | 1 (0.5) | 0 |
| Pulmonary fibrosis | 0 | 0 | 1 (0.5) | 0 |
| Exanthema erythematous | 0 | 0 | 0 | 2 (0.9) |
| Perniosis | 1 (0.5) | 0 | 0 | 0 |
| Hair loss | 0 | 1 (0.5) | 2 (0.9) | 2 (0.9) |
| Ketoacidosis | 0 | 1 (0.5) | 0 | 0 |
| Behavior change | 0 | 0 | 1 (0.5) | 0 |
| Anxiety | 0 | 1 (0.5) | 0 | 0 |
| Depression | 0 | 1 (0.5) | 0 | 0 |
| Thrombosis | 0 | 0 | 1 (0.5) | 0 |
| D-dimer elevation | 0 | 0 | 0 | 2 (0.9) |
a
MIS-C, Multisystem Inflammatory Syndrome in Children.